Egypt
Case Report
Evaluation of Acitretin in the Treatment of Multiple Recalcitrant Common Warts: a Pilot Study
Author(s): Ibrahim El Gharib, Dalia Gamal Aly, Hanaa Mohamed Emam and Omnia Hani KhaterIbrahim El Gharib, Dalia Gamal Aly, Hanaa Mohamed Emam and Omnia Hani Khater
Background: Oral acitretin, a synthetic compound of retinoids, seems to be a promising modality in treating warts. To the best of our knowledge, no studies regarding its use have been performed on Egyptian patients. Objectives: Evaluating the role of acitretin in the treatment of multiple recalcitrant common warts. Patients and Methods: Forty adult patients with multiple recalcitrant warts were treated with oral acitretin [20 with 1 mg/kg/day for 3 month (group A), 20 with 0.5 mg/kg/day for 3 months (group B), and 20 served as controls and were given placebo (group C)]. Results: Oral acitretin was found to be a statistically significant therapy compared to placebo in treating warts. Total clearance of lesions was noted in 70% of group A compared to 80% in group B and none in group C. A non significant difference between group A and B was noted. However, there was a significant relatio.. Read More»
DOI:
10.4172/2376-0427.1000183
Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report